NEWS

Afrigen Biologics, the development lead in the mRNA technology transfer programme  and Dillico Announce Cooperative R&D Agreement to test a new continuous mRNA Manufacturing Solution adapted for low- and middle-income countries. Cape Town, [...]

We are pleased to announce today that Flora Binder has taken up her role of Dillico’s Chief Development Officer. “Flora has a solid expertise in mRNA process transfer in the global pharmaceutical industry and it will be a significant asset to Dillico to advance our [...]

Dillico is pleased to announce that it has been awarded a French Tech Emergence grant by BPIFrance, which we thank. This financial support is granted to startup projects that develop a disruptive innovation [...]